Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens

TP-271 is a novel, fully synthetic fluorocycline antibiotic in clinical development for the treatment of respiratory infections caused by susceptible and multidrug-resistant pathogens. TP-271 was active in MIC assays against key community respiratory Gram-positive and Gram-negative pathogens, includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossman, Trudy H., Fyfe, Corey, O’Brien, William, Hackel, Meredith, Minyard, Mary Beth, Waites, Ken B., Dubois, Jacques, Murphy, Timothy M., Slee, Andrew M., Weiss, William J., Sutcliffe, Joyce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322343/
https://www.ncbi.nlm.nih.gov/pubmed/28251179
http://dx.doi.org/10.1128/mSphere.00004-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322343/
https://www.ncbi.nlm.nih.gov/pubmed/28251179
http://dx.doi.org/10.1128/mSphere.00004-17

Ejemplares similares